跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
首頁
概要
研究單位
研究成果
專案
學生論文
設備
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 美瑾
教授
化學工程學系
電子郵件
kokola
mail.ncku.edu
tw
h-index
4369
引文
32
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2023
每年研究成果
概覽
指紋
網路
專案
(19)
研究成果
(53)
類似的個人檔案
(6)
監製作品
(14)
如果您對這些純文本內容做了任何改變，很快就會看到。
指紋
查看啟用 Mei-Chin Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Engineering & Materials Science
Acids
42%
Alginate
11%
Antigens
29%
Antioxidants
11%
Atopic Dermatitis
44%
Biological Availability
21%
Block copolymers
30%
Chemotherapy
13%
Chitosan
100%
Crosslinking
18%
Crystallization kinetics
11%
Drug delivery
39%
Drug Delivery Systems
27%
Galactosamine
18%
Gold nanoparticles
11%
Heparin
28%
Homopolymerization
11%
Hydrogels
19%
Infrared radiation
26%
Insulin
30%
Lanthanum
9%
Lasers
9%
Liver
12%
Macromolecules
10%
Micelles
17%
Milk
10%
Molecules
12%
Muscle
9%
Nanofibers
9%
Nanoparticles
39%
Nanostructures
13%
Phase behavior
9%
Photodynamic therapy
13%
Polyaniline
11%
Polycaprolactone
16%
Polyethylene glycols
13%
Polyethylene oxides
10%
Polymers
19%
Polyphenols
25%
Proteins
13%
Rats
25%
Self assembly
9%
Shape memory effect
9%
Skin
56%
Stents
51%
Targeted drug delivery
26%
Tissue
16%
Tissue engineering
11%
Tumors
13%
Vaccines
15%
Chemical Compounds
Ablation
8%
Adjuvant
11%
Alcohol
14%
Alginate
7%
Antigen
21%
Antiinflammatory
8%
Antioxidant Agent
6%
Bioavailability
14%
Biopolymer
7%
Block Copolymer
23%
Chitosan
81%
Collagen
10%
Crosslinking
16%
Curcumin
8%
Doxorubicin
7%
Drug
63%
Fibrous Crystal
7%
Galactosamine
14%
Gallate
9%
Genipin
12%
Geniposidic Acid
26%
Heat
7%
Heparin
24%
Hyaluronate
10%
Hydrogel
13%
Immunological Adjuvant
6%
Insulin Derivative
23%
Intradermal
36%
Liquid Film
8%
Macromolecule
12%
Micelle
14%
Multilayer
13%
Nanomaterial
14%
Nanoparticle
26%
Nanoporosity
7%
Paclitaxel
9%
pH Value
8%
Phase Behavior
7%
Pluronic
10%
Polyphenol
7%
Single Monomer Polymer
7%
Sirolimus
50%
Strength
7%
Tannic Acid
9%
Transdermal
36%
Weight
9%
Medicine & Life Sciences
Alginates
8%
Antigens
17%
Atopic Dermatitis
15%
Biological Availability
10%
Chitosan
72%
Drug Delivery Systems
16%
Drug-Eluting Stents
11%
epigallocatechin gallate
9%
Galactosamine
13%
Gas Lasers
9%
geniposidic acid
14%
Glutamic Acid
40%
Heparin
8%
Histocompatibility Antigens Class II
8%
Hydrogels
16%
Immunization
9%
Immunologic Factors
9%
Insulin
15%
Lasers
12%
Liver Neoplasms
11%
Micelles
11%
Nanofibers
9%
Nanoparticles
42%
O,N-carboxymethylchitosan
14%
Ovalbumin
9%
Paclitaxel
15%
Pharmaceutical Preparations
25%
Poloxamer
11%
poly(lactide)
37%
polyaniline
13%
polycaprolactone
17%
Polymers
13%
Polyvinyl Alcohol
10%
Prostaglandins A
24%
Reducing Agents
9%
Sirolimus
19%
Skin
24%
Stents
19%
Streptococcus suis
11%
Tissue Engineering
8%
Vaccination
20%
Vaccines
17%
Zika Virus
10%
